NON-THERMAL NANOKNIFE & CONVERSION THERAPY

Advanced Pancreatic Cancer Care in China

Pancreatic cancer is notoriously challenging because tumors frequently wrap around major abdominal blood vessels. China’s top pancreatic cancer centers are global leaders in irreversible electroporation (NanoKnife ablation), complex vascular reconstruction surgery, and multi-agent conversion therapies designed to turn inoperable tumors into candidates for successful surgical removal.

  • Pancreatic Adenocarcinoma & Neuroendocrine Tumors (pNET)
  • Locally Advanced Tumors Enveloping Celiac or Mesenteric Arteries
  • Patients Seeking Safe Ablation Without Thermal Vessel Damage
  • World-Leading Experience in NanoKnife (IRE) Electroporation
  • Specialized Arterial & Venous Vascular Reconstruction Surgery
  • Multidisciplinary Board of Pancreatic Surgeons & Interventionalists

ELECTROPORATION, SURGERY & SYSTEMIC THERAPIES

Key Pancreatic Cancer Treatments in China

Non-thermal NanoKnife (IRE) ablation, vascular reconstruction surgery, and multi-agent conversion therapy.

Non-Thermal NanoKnife (IRE)

Uses microsecond high-voltage electrical pulses to open pores in cancer cells and destroy them, leaving blood vessels, bile ducts, and nerves completely intact.
Learn More

Vascular Reconstruction Surgery

Specialized surgical teams capable of resecting tumors intertwined with major abdominal vessels and reconstructing the blood supply safely.
Learn More

Intensive Conversion Regimens

Advanced multi-agent systemic chemotherapy paired with novel targeted drugs to shrink stubborn tumors into surgically resectable stages.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Pancreatic Cancer Care

A specialized clinical pathway connecting international patients with China’s highest-volume pancreatic surgery institutes.

China has accumulated extensive clinical volume in treating locally advanced pancreatic cancer using Irreversible Electroporation (IRE NanoKnife). Unlike heat-based ablation, IRE uses non-thermal electrical fields that safely destroy tumor cells right up to the vessel walls without damaging vital blood supply.

Pancreatic surgical centers in China routinely perform high-difficulty Whipple procedures and total pancreatectomies with vascular resection and reconstruction. All treatment plans are reviewed by a dedicated pancreatic MDT with transparent hospital fee schedules.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload pathology reports, biomarker NGS profiles, and imaging scans through our confidential clinical intake portal.

02. Remote MDT Review

National Clinical Research Center oncology boards evaluate eligibility, target expression, and formulate a customized protocol.

03. Visa & Admission

Receive official hospital medical invitation letters, transparent pricing schedules, and expedited department admission.

04. Treatment & Follow-up

Inpatient cellular or particle therapy in ISO-GMP cleanrooms with dedicated bilingual escorts and remote post-discharge care.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Pancreatic Cancer patients considering advanced treatment in China.

NanoKnife sends electrical pulses that puncture cancer cell membranes without generating heat. This protects the delicate celiac axis and superior mesenteric artery from burn damage.
Yes. With intensive modern conversion regimens combining chemotherapy, targeted therapies, and local ablation, a significant proportion of borderline and locally advanced tumors shrink enough for surgery.
In high-volume Chinese centers, specialized post-operative care and robotic approaches enable patients to walk within 48 hours and achieve discharge within 10 to 14 days.
Your contrast-enhanced thin-slice pancreatic CT/MRI scans are analyzed by senior pancreatic surgeons and interventional radiologists to assess vessel involvement and eligibility.

PANCREATIC ONCOLOGY CLINICAL ASSESSMENT

Request a Confidential Case Review for Pancreatic Cancer

Upload your thin-slice pancreatic CT/MRI scans, biopsy records, and tumor marker levels (CA19-9) for a detailed evaluation by our pancreatic tumor board.

    Pancreatic Cancer